Chemomab Therapeutics Statistics

Total Valuation

CMMB has a market cap or net worth of $10.62 million. The enterprise value is $146,565.

Market Cap	10.62M
Enterprise Value	146,565

Important Dates

The next estimated earnings date is Thursday, May 14, 2026, before market open.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

CMMB has 7.20 million shares outstanding. The number of shares has increased by 42.11% in one year.

Current Share Class	n/a
Shares Outstanding	7.20M
Shares Change (YoY)	+42.11%
Shares Change (QoQ)	+26.57%
Owned by Insiders (%)	11.84%
Owned by Institutions (%)	9.47%
Float	6.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.90
P/TBV Ratio	0.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.08

Current Ratio	9.08
Quick Ratio	7.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.54% and return on invested capital (ROIC) is -45.65%.

Return on Equity (ROE)	-69.54%
Return on Assets (ROA)	-38.86%
Return on Invested Capital (ROIC)	-45.65%
Return on Capital Employed (ROCE)	-77.57%
Weighted Average Cost of Capital (WACC)	7.46%
Revenue Per Employee	n/a
Profits Per Employee	-$3.00M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.85% in the last 52 weeks. The beta is 0.58, so CMMB's price volatility has been lower than the market average.

Beta (5Y)	0.58
52-Week Price Change	-71.85%
50-Day Moving Average	1.70
200-Day Moving Average	2.52
Relative Strength Index (RSI)	35.07
Average Volume (20 Days)	36,062

Short Selling Information

The latest short interest is 50,281, so 0.72% of the outstanding shares have been sold short.

Short Interest	50,281
Short Previous Month	47,427
Short % of Shares Out	0.72%
Short % of Float	n/a
Short Ratio (days to cover)	1.13

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-9.57M
Pretax Income	-9.00M
Net Income	-9.00M
EBITDA	-9.50M
EBIT	-9.57M
Earnings Per Share (EPS)	-$1.41

Full Income Statement

Balance Sheet

The company has $10.37 million in cash and n/a in debt, giving a net cash position of $10.37 million or $1.44 per share.

Cash & Cash Equivalents	10.37M
Total Debt	n/a
Net Cash	10.37M
Net Cash Per Share	$1.44
Equity (Book Value)	12.33M
Book Value Per Share	1.71
Working Capital	11.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$11.13 million and capital expenditures -$3,000, giving a free cash flow of -$11.13 million.

Operating Cash Flow	-11.13M
Capital Expenditures	-3,000
Depreciation & Amortization	70,000
Net Borrowing	n/a
Free Cash Flow	-11.13M
FCF Per Share	-$1.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CMMB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.11%
Shareholder Yield	-42.11%
Earnings Yield	-85.56%
FCF Yield	-105.90%

Analyst Forecast

The average price target for CMMB is $25.00, which is 1,594.92% higher than the current price. The consensus rating is "Buy".

Price Target	$25.00
Price Target Difference	1,594.92%
Analyst Consensus	Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 26, 2025. It was a reverse split with a ratio of 1:4.

Last Split Date	Aug 26, 2025
Split Type	Reverse
Split Ratio	1:4

Scores

Altman Z-Score	n/a
Piotroski F-Score	1